{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:08:26Z","timestamp":1795028906190,"version":"4.10.2"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34214-w","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T01:58:27Z","timestamp":1767491907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["2'-Nitroflavone targets PARP1 and alters cytoskeleton to inhibit triple-negative breast cancer progression"],"prefix":"10.1038","volume":"16","author":[{"given":"Vanina S.","family":"Vachetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana C.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariel","family":"Marder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa B.","family":"Nicoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Benso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Vanzulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda G.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot Paulino","family":"Zunini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanina A.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda T.","family":"Elola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda F.","family":"Troncoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"34214_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752 (2000).","journal-title":"Nature"},{"key":"34214_CR2","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat, A. et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 12, R68 (2010).","journal-title":"Breast Cancer Res."},{"key":"34214_CR3","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Network.\u00a0Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","DOI":"10.1038\/nature11412"},{"key":"34214_CR4","unstructured":"GLOBOCAN 2022. https:\/\/gco.iarc.who.int\/today\/en."},{"key":"34214_CR5","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121, 2750\u20132767 (2011).","journal-title":"J. Clin. Invest."},{"key":"34214_CR6","doi-asserted-by":"publisher","first-page":"e0157368","DOI":"10.1371\/journal.pone.0157368","volume":"11","author":"BD Lehmann","year":"2016","unstructured":"Lehmann, B. D. et al. Refinement of triple-negative breast cancer molecular subtypes: Implications for neoadjuvant chemotherapy selection. PLoS ONE 11, e0157368. https:\/\/doi.org\/10.1371\/journal.pone.0157368 (2016).","journal-title":"PLoS ONE"},{"key":"34214_CR7","doi-asserted-by":"publisher","first-page":"6276","DOI":"10.1038\/s41467-021-26502-6","volume":"12","author":"BD Lehmann","year":"2021","unstructured":"Lehmann, B. D. et al. Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes. Nat. Commun. 12, 6276. https:\/\/doi.org\/10.1038\/s41467-021-26502-6 (2021).","journal-title":"Nat. Commun."},{"key":"34214_CR8","doi-asserted-by":"publisher","first-page":"115170","DOI":"10.1016\/j.biopha.2023.115170","volume":"165","author":"R Farghadani","year":"2023","unstructured":"Farghadani, R. & Naidu, R. The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC). Biomed. Pharmacother. 165, 115170 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"34214_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/15384047.2017.1294288","volume":"18","author":"H Sun","year":"2017","unstructured":"Sun, H. et al. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry. Cancer Biol. Ther. 18, 205\u2013213 (2017).","journal-title":"Cancer Biol. Ther."},{"key":"34214_CR10","doi-asserted-by":"publisher","first-page":"1513421","DOI":"10.3389\/fimmu.2024.1513421","volume":"15","author":"L Serrano Garc\u00eda","year":"2024","unstructured":"Serrano Garc\u00eda, L. et al. Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: A review. Front. Immunol. 15, 1513421. https:\/\/doi.org\/10.3389\/fimmu.2024.1513421 (2024).","journal-title":"Front. Immunol."},{"key":"34214_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2174\/1568009622666211231140623","volume":"22","author":"DYJ Ke","year":"2022","unstructured":"Ke, D. Y. J., El-Sahli, S. & Wang, L. The potential of natural products in the treatment of triple-negative breast cancer. Curr. Cancer Drug Targets 22, 388\u2013403 (2022).","journal-title":"Curr. Cancer Drug Targets"},{"key":"34214_CR12","doi-asserted-by":"publisher","first-page":"162750","DOI":"10.1155\/2013\/162750","volume":"2013","author":"S Kumar","year":"2013","unstructured":"Kumar, S. & Pandey, A. K. Chemistry and biological activities of flavonoids: An overview. Sci. World J. 2013, 162750 (2013).","journal-title":"Sci. World J."},{"key":"34214_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fonc.2019.00487","volume":"9","author":"Q Ye","year":"2019","unstructured":"Ye, Q. et al. Reversal of multidrug resistance in cancer by multi-functional flavonoids. Front. Oncol. 9, 487. https:\/\/doi.org\/10.3389\/fonc.2019.00487 (2019).","journal-title":"Front. Oncol."},{"key":"34214_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0955-2863(02)00208-5","volume":"13","author":"KE Heim","year":"2002","unstructured":"Heim, K. E., Tagliaferro, A. R. & Bobilya, D. J. Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem. 13, 572\u2013584 (2002).","journal-title":"J. Nutr. Biochem."},{"key":"34214_CR15","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/ptr.5023","volume":"27","author":"B Romano","year":"2013","unstructured":"Romano, B. et al. Novel insights into the pharmacology of flavonoids. Phytother. Res. 27, 1588\u20131596 (2013).","journal-title":"Phytother. Res."},{"key":"34214_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25225243","author":"A Ullah","year":"2020","unstructured":"Ullah, A. et al. Important flavonoids and their role as a therapeutic agent. Molecules https:\/\/doi.org\/10.3390\/molecules25225243 (2020).","journal-title":"Molecules"},{"key":"34214_CR17","first-page":"100077","volume":"6","author":"VS Vachetta","year":"2022","unstructured":"Vachetta, V. S., Marder, M., Troncoso, M. F. & Elola, M. T. Opportunities, obstacles and current challenges of flavonoids for luminal and triple-negative breast cancer therapy. Eur. J. Med. Chem. Reports 6, 100077 (2022).","journal-title":"Eur. J. Med. Chem. Reports"},{"key":"34214_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3892\/ijmm.2012.990","volume":"30","author":"H Pan","year":"2012","unstructured":"Pan, H. et al. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-\u03baB activity via the Notch-1 pathway. Int. J. Mol. Med. 30, 337\u2013343 (2012).","journal-title":"Int. J. Mol. Med."},{"key":"34214_CR19","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/s41598-018-37796-w","volume":"9","author":"NA Razak","year":"2019","unstructured":"Razak, N. A. et al. Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis. Sci. Rep. 9, 1514. https:\/\/doi.org\/10.1038\/s41598-018-37796-w (2019).","journal-title":"Sci. Rep."},{"key":"34214_CR20","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1007\/s00210-020-01917-y","volume":"393","author":"M Moradi","year":"2020","unstructured":"Moradi, M. et al. Flavonoid calycopterin triggers apoptosis in triple-negative and ER-positive human breast cancer cells through activating different patterns of gene expression. Naunyn. Schmiedebergs. Arch. Pharmacol. 393, 2145\u20132156 (2020).","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"34214_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.canlet.2008.03.062","volume":"268","author":"MG C\u00e1rdenas","year":"2008","unstructured":"C\u00e1rdenas, M. G., Blank, V. C., Marder, M. & Roguin, L. P. 2\u2019-Nitroflavone induces cell cycle arrest and apoptosis in HeLa human cervical carcinoma cells. Cancer Lett. 268, 146\u2013157 (2008).","journal-title":"Cancer Lett."},{"key":"34214_CR22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/CAD.0b013e328353f947","volume":"23","author":"MG C\u00e1rdenas","year":"2012","unstructured":"C\u00e1rdenas, M. G., Blank, V. C., Marder, M. N. & Roguin, L. P. 2\u2019-Nitroflavone induces apoptosis and modulates mitogen-activated protein kinase pathways in human leukaemia cells. Anticancer. Drugs 23, 815\u2013826 (2012).","journal-title":"Anticancer. Drugs"},{"key":"34214_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ijc.24361","volume":"125","author":"MG C\u00e1rdenas","year":"2009","unstructured":"C\u00e1rdenas, M. G., Zotta, E., Marder, M. & Roguin, L. P. In vitro induction of apoptosis and in vivo effects of a flavone nitroderivative in murine mammary adenocarcinoma cells. Int. J. Cancer 125, 222\u2013228 (2009).","journal-title":"Int. J. Cancer"},{"key":"34214_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tcb.2009.01.006","volume":"19","author":"P Kunda","year":"2009","unstructured":"Kunda, P. & Baum, B. The actin cytoskeleton in spindle assembly and positioning. Trends Cell Biol. 19, 174\u2013179 (2009).","journal-title":"Trends Cell Biol."},{"key":"34214_CR25","doi-asserted-by":"publisher","first-page":"a023218","DOI":"10.1101\/cshperspect.a023218","volume":"8","author":"JR McIntosh","year":"2016","unstructured":"McIntosh, J. R. Mitosis. Cold Spring Harb. Perspect. Biol. 8, a023218 (2016).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"34214_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.phymed.2018.09.012","volume":"50","author":"XL Hu","year":"2018","unstructured":"Hu, X. L. et al. Identification of amentoflavone as a potent highly selective PARP-1 inhibitor and its potentiation on carboplatin in human non-small cell lung cancer. Phytomedicine 50, 88\u201398 (2018).","journal-title":"Phytomedicine"},{"key":"34214_CR27","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1021\/jm3018783","volume":"56","author":"M Narwal","year":"2013","unstructured":"Narwal, M., Haikarainen, T., Fallarero, A., Vuorela, P. M. & Lehti\u00f6, L. Screening and structural analysis of flavones inhibiting tankyrases. J. Med. Chem. 56, 3507\u20133517 (2013).","journal-title":"J. Med. Chem."},{"key":"34214_CR28","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.1038\/s41598-019-41984-7","volume":"9","author":"S Alam","year":"2019","unstructured":"Alam, S. & Khan, F. 3D-QSAR, docking, ADME\/Tox studies on flavone analogs reveal anticancer activity through Tankyrase inhibition. Sci. Rep. 9, 5414 (2019).","journal-title":"Sci. Rep."},{"key":"34214_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ijbiomac.2019.08.242","volume":"141","author":"A Mitra","year":"2019","unstructured":"Mitra, A., Biswas, R., Bagchi, A. & Ghosh, R. Insight into the binding of a synthetic nitro-flavone derivative with human poly (ADP-ribose) polymerase 1. Int. J. Biol. Macromol. 141, 444\u2013459 (2019).","journal-title":"Int. J. Biol. Macromol."},{"key":"34214_CR30","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1107\/S2056989020010713","volume":"76","author":"E Oskolkov","year":"2020","unstructured":"Oskolkov, E., Kornilova, T., Chavez, P. A., Tillotson, J. P. & Timofeeva, T. V. Structural (at 100K) and DFT studies of 2\u2019-nitro-flavone. Acta Crystallogr. Sect. E Crystallogr. Commun. 76, 1417\u20131420 (2020).","journal-title":"Acta Crystallogr. Sect. E Crystallogr. Commun."},{"key":"34214_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1074\/jbc.RA120.016573","volume":"296","author":"K Ryan","year":"2021","unstructured":"Ryan, K. et al. Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1. J. Biol. Chem. 296, 1\u201313 (2021).","journal-title":"J. Biol. Chem."},{"key":"34214_CR32","doi-asserted-by":"crossref","unstructured":"Bochum, S., Berger, S. & Martens, U. M. Olaparib. In: Small Molecules in Oncology. Recent results in cancer research. (ed. Martens, U. M.) 217\u2013233 (Springer, Cham, 2018).","DOI":"10.1007\/978-3-319-91442-8_15"},{"key":"34214_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bmcl.2003.10.029","volume":"14","author":"VC Blank","year":"2004","unstructured":"Blank, V. C., Poli, C., Marder, M. & Roguin, L. P. Antiproliferative activity of various flavonoids and related compounds: Additive effect of interferon-alpha2b. Bioorg. Med. Chem. Lett. 14, 133\u2013136 (2004).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"34214_CR34","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1016\/j.bmc.2005.12.021","volume":"14","author":"M C\u00e1rdenas","year":"2006","unstructured":"C\u00e1rdenas, M., Marder, M., Blank, V. C. & Roguin, L. P. Antitumor activity of some natural flavonoids and synthetic derivatives on various human and murine cancer cell lines. Bioorganic Med. Chem. 14, 2966\u20132971 (2006).","journal-title":"Bioorganic Med. Chem."},{"key":"34214_CR35","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00109-024-02497-7","volume":"102","author":"JM Anselmi Relats","year":"2024","unstructured":"Anselmi Relats, J. M. et al. Synergistic effect of the sphingosine kinase inhibitor safingol in combination with 2\u2019-nitroflavone in breast cancer. J. Mol. Med. (Berl) 102, 1503\u20131516 (2024).","journal-title":"J. Mol. Med. (Berl)"},{"key":"34214_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore, S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 35, 495\u2013516 (2007).","journal-title":"Toxicol. Pathol."},{"key":"34214_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.18632\/aging.100934","volume":"8","author":"G Pistritto","year":"2016","unstructured":"Pistritto, G., Trisciuoglio, D., Ceci, C., Garufi, A. & D\u2019Orazi, G. Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY) 8, 603\u2013619 (2016).","journal-title":"Aging (Albany NY)"},{"key":"34214_CR38","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/jcb.25490","volume":"117","author":"ML Smith","year":"2016","unstructured":"Smith, M. L., Murphy, K., Doucette, C. D., Greenshields, A. L. & Hoskin, D. W. The dietary flavonoid fisetin causes cell cycle arrest, caspase-dependent apoptosis, and enhanced cytotoxicity of chemotherapeutic drugs in triple-negative breast cancer cells. J. Cell. Biochem. 117, 1913\u20131925 (2016).","journal-title":"J. Cell. Biochem."},{"key":"34214_CR39","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/cdd.2008.47","volume":"15","author":"H Vakifahmetoglu","year":"2008","unstructured":"Vakifahmetoglu, H., Olsson, M. & Zhivotovsky, B. Death through a tragedy: Mitotic catastrophe. Cell Death Differ. 15, 1153\u20131162 (2008).","journal-title":"Cell Death Differ."},{"key":"34214_CR40","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrm3115","volume":"12","author":"I Vitale","year":"2011","unstructured":"Vitale, I., Galluzzi, L., Castedo, M. & Kroemer, G. Mitotic catastrophe: A mechanism for avoiding genomic instability. Nat. Rev. Mol. Cell Biol. 12, 385\u2013392 (2011).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"34214_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/cdd.2011.96","volume":"19","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi, L. et al. Molecular definitions of cell death subroutines: Recommendations of the nomenclature committee on cell death 2012. Cell Death Differ. 19, 107\u2013120 (2012).","journal-title":"Cell Death Differ."},{"key":"34214_CR42","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: Recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 25, 486\u2013541 (2018).","journal-title":"Cell Death Differ."},{"key":"34214_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13062-021-00313-7","volume":"16","author":"EV Sazonova","year":"2021","unstructured":"Sazonova, E. V., Petrichuk, S. V., Kopeina, G. S. & Zhivotovsky, B. A link between mitotic defects and mitotic catastrophe: Detection and cell fate. Biol. Direct 16, 25 (2021).","journal-title":"Biol. Direct"},{"key":"34214_CR44","doi-asserted-by":"publisher","first-page":"188965","DOI":"10.1016\/j.bbcan.2023.188965","volume":"1878","author":"Z Bai","year":"2023","unstructured":"Bai, Z., Zhou, Y., Peng, Y., Ye, X. & Ma, L. Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment. Biochim. Biophys. acta. Rev. cancer 1878, 188965 (2023).","journal-title":"Biochim. Biophys. acta. Rev. cancer"},{"key":"34214_CR45","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1101\/gad.263202.115","volume":"29","author":"NT Pfister","year":"2015","unstructured":"Pfister, N. T. et al. Mutant p53 cooperates with the SWI\/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells. Genes Dev. 29, 1298\u20131315 (2015).","journal-title":"Genes Dev."},{"key":"34214_CR46","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ejmech.2019.03.025","volume":"171","author":"F Naaz","year":"2019","unstructured":"Naaz, F., Haider, M. R., Shafi, S. & Yar, M. S. Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains. Eur. J. Med. Chem. 171, 310\u2013331 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"34214_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.canlet.2015.07.030","volume":"367","author":"E Mukhtar","year":"2015","unstructured":"Mukhtar, E., Adhami, V. M., Sechi, M. & Mukhtar, H. Dietary flavonoid fisetin binds to \u03b2-tubulin and disrupts microtubule dynamics in prostate cancer cells. Cancer Lett. 367, 173\u2013183 (2015).","journal-title":"Cancer Lett."},{"key":"34214_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/14756366.2021.1976772","volume":"37","author":"W Liu","year":"2022","unstructured":"Liu, W., He, M., Li, Y., Peng, Z. & Wang, G. A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors. J. Enzyme Inhib. Med. Chem. 37, 9\u201338 (2022).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"34214_CR49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ceb.2018.10.003","volume":"56","author":"I Gasic","year":"2019","unstructured":"Gasic, I. & Mitchison, T. J. Autoregulation and repair in microtubule homeostasis. Curr. Opin. Cell Biol. 56, 80\u201387 (2019).","journal-title":"Curr. Opin. Cell Biol."},{"key":"34214_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ceb.2020.09.005","volume":"68","author":"R Ohi","year":"2021","unstructured":"Ohi, R., Strothman, C. & Zanic, M. Impact of the \u2018tubulin economy\u2019 on the formation and function of the microtubule cytoskeleton. Curr. Opin. Cell Biol. 68, 81\u201389 (2021).","journal-title":"Curr. Opin. Cell Biol."},{"key":"34214_CR51","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0092-8674(79)90157-0","volume":"17","author":"A Ben-Ze\u2019ev","year":"1979","unstructured":"Ben-Ze\u2019ev, A., Farmer, S. R. & Penman, S. Mechanisms of regulating tubulin synthesis in cultured mammalian cells. Cell 17, 319\u2013325 (1979).","journal-title":"Cell"},{"key":"34214_CR52","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/0092-8674(81)90072-6","volume":"25","author":"DW Cleveland","year":"1981","unstructured":"Cleveland, D. W., Lopata, M. A., Sherline, P. & Kirschner, M. W. Unpolymerized tubulin modulates the level of tubulin mRNAs. Cell 25, 537\u2013546 (1981).","journal-title":"Cell"},{"key":"34214_CR53","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1124\/mol.119.117812","volume":"96","author":"J Yang","year":"2019","unstructured":"Yang, J. et al. The natural compound with Aferin A covalently binds to Cys239 of \u03b2-tubulin to promote tubulin degradation. Mol. Pharmacol. 96, 711\u2013719 (2019).","journal-title":"Mol. Pharmacol."},{"key":"34214_CR54","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1074\/jbc.RA118.006325","volume":"294","author":"J Yang","year":"2019","unstructured":"Yang, J. et al. Covalent modification of Cys-239 in \u03b2-tubulin by small molecules as a strategy to promote tubulin heterodimer degradation. J. Biol. Chem. 294, 8161\u20138170 (2019).","journal-title":"J. Biol. Chem."},{"key":"34214_CR55","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/ncb3481","volume":"19","author":"D Portran","year":"2017","unstructured":"Portran, D., Schaedel, L., Xu, Z., Th\u00e9ry, M. & Nachury, M. V. Tubulin acetylation protects long-lived microtubules against mechanical ageing. Nat. Cell Biol. 19, 391\u2013398 (2017).","journal-title":"Nat. Cell Biol."},{"key":"34214_CR56","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1073\/pnas.1900441116","volume":"116","author":"L Eshun-Wilson","year":"2019","unstructured":"Eshun-Wilson, L. et al. Effects of \u03b1-tubulin acetylation on microtubule structure and stability. Proc. Natl. Acad. Sci. U. S. A. 116, 10366\u201310371 (2019).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"34214_CR57","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.aai8764","volume":"356","author":"Z Xu","year":"2017","unstructured":"Xu, Z. et al. Microtubules acquire resistance from mechanical breakage through intralumenal acetylation. Science 356, 328\u2013332 (2017).","journal-title":"Science"},{"key":"34214_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1152\/physrev.00018.2013","volume":"94","author":"L Blanchoin","year":"2014","unstructured":"Blanchoin, L., Boujemaa-Paterski, R., Sykes, C. & Plastino, J. Actin dynamics, architecture, and mechanics in cell motility. Physiol. Rev. 94, 235\u2013263 (2014).","journal-title":"Physiol. Rev."},{"key":"34214_CR59","first-page":"1855","volume":"125","author":"S Tojkander","year":"2012","unstructured":"Tojkander, S., Gateva, G. & Lappalainen, P. Actin stress fibers\u2013assembly, dynamics and biological roles. J. Cell Sci. 125, 1855\u20131864 (2012).","journal-title":"J. Cell Sci."},{"key":"34214_CR60","first-page":"599","volume":"1846","author":"M Trendowski","year":"2014","unstructured":"Trendowski, M. Exploiting the cytoskeletal filaments of neoplastic cells to potentiate a novel therapeutic approach. Biochim. Biophys. Acta 1846, 599\u2013616 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"34214_CR61","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0962-8924(00)01747-5","volume":"10","author":"DN Robinson","year":"2000","unstructured":"Robinson, D. N. & Spudich, J. A. Towards a molecular understanding of cytokinesis. Trends Cell Biol. 10, 228\u2013237 (2000).","journal-title":"Trends Cell Biol."},{"key":"34214_CR62","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cub.2005.02.055","volume":"15","author":"K Murthy","year":"2005","unstructured":"Murthy, K. & Wadsworth, P. Myosin-II-dependent localization and dynamics of F-actin during cytokinesis. Curr. Biol. 15, 724\u2013731 (2005).","journal-title":"Curr. Biol."},{"key":"34214_CR63","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1756-9966-28-44","volume":"28","author":"T Ariizumi","year":"2009","unstructured":"Ariizumi, T. et al. Multinucleation followed by an acytokinetic cell division in myxofibrosarcoma with giant cell proliferation. J. Exp. Clin. cancer Res. 28, 44 (2009).","journal-title":"J. Exp. Clin. cancer Res."},{"key":"34214_CR64","doi-asserted-by":"publisher","first-page":"146282","DOI":"10.1155\/2015\/146282","volume":"2015","author":"MM Mc Gee","year":"2015","unstructured":"Mc Gee, M. M. Targeting the mitotic catastrophe signaling pathway in cancer. Mediat. Inflamm. 2015, 146282 (2015).","journal-title":"Mediat. Inflamm."},{"key":"34214_CR65","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/ncb2958","volume":"16","author":"H Maiato","year":"2014","unstructured":"Maiato, H. & Logarinho, E. Mitotic spindle multipolarity without centrosome amplification. Nat. Cell Biol. 16, 386\u2013394 (2014).","journal-title":"Nat. Cell Biol."},{"key":"34214_CR66","doi-asserted-by":"publisher","first-page":"e3002339","DOI":"10.1371\/journal.pbio.3002339","volume":"21","author":"AS Zhou","year":"2023","unstructured":"Zhou, A. S. et al. Diverse microtubule-targeted anticancer agents kill cells by inducing chromosome missegregation on multipolar spindles. PLoS Biol. 21, e3002339. https:\/\/doi.org\/10.1371\/journal.pbio.3002339 (2023).","journal-title":"PLoS Biol."},{"key":"34214_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21050663","author":"Y Nakayama","year":"2016","unstructured":"Nakayama, Y. & Inoue, T. Antiproliferative fate of the tetraploid formed after mitotic slippage and its promotion; a novel target for cancer therapy based on microtubule poisons. Molecules https:\/\/doi.org\/10.3390\/molecules21050663 (2016).","journal-title":"Molecules"},{"key":"34214_CR68","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/cells8040362","volume":"8","author":"T Hohmann","year":"2019","unstructured":"Hohmann, T. & Dehghani, F. The cytoskeleton\u2014A complex interacting meshwork. Cells 8, 362 (2019).","journal-title":"Cells"},{"key":"34214_CR69","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.tcb.2020.06.004","volume":"30","author":"S Seetharaman","year":"2020","unstructured":"Seetharaman, S. & Etienne-Manneville, S. Cytoskeletal crosstalk in Cell migration. Trends Cell Biol. 30, 720\u2013735 (2020).","journal-title":"Trends Cell Biol."},{"key":"34214_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010027","author":"L Mirossay","year":"2017","unstructured":"Mirossay, L., Varinsk\u00e1, L. & Moj\u017ei\u0161, J. Antiangiogenic effect of flavonoids and chalcones: An update. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms19010027 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"34214_CR71","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1254\/jphs.09213FP","volume":"112","author":"Y Chen","year":"2010","unstructured":"Chen, Y. et al. LYG-202, a newly synthesized flavonoid, exhibits potent anti-angiogenic activity in vitro and in vivo. J. Pharmacol. Sci. 112, 37\u201345 (2010).","journal-title":"J. Pharmacol. Sci."},{"key":"34214_CR72","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bcp.2013.09.007","volume":"87","author":"J Fan","year":"2014","unstructured":"Fan, J. & de Lannoy, I. A. M. Pharmacokinetics. Biochem. Pharmacol. 87, 93\u2013120 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"34214_CR73","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","volume":"24","author":"LLG Ferreira","year":"2019","unstructured":"Ferreira, L. L. G. & Andricopulo, A. D. ADMET modeling approaches in drug discovery. Drug Discov. Today 24, 1157\u20131165 (2019).","journal-title":"Drug Discov. Today"},{"key":"34214_CR74","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.drudis.2019.10.014","volume":"25","author":"C-Y Jia","year":"2020","unstructured":"Jia, C.-Y., Li, J.-Y., Hao, G.-F. & Yang, G.-F. A drug-likeness toolbox facilitates ADMET study in drug discovery. Drug Discov. Today 25, 248\u2013258 (2020).","journal-title":"Drug Discov. Today"},{"key":"34214_CR75","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717. https:\/\/doi.org\/10.1038\/srep42717 (2017).","journal-title":"Sci. Rep."},{"key":"34214_CR76","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","volume":"35","author":"H Yang","year":"2019","unstructured":"Yang, H. et al. admetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties. Bioinformatics 35, 1067\u20131069. https:\/\/doi.org\/10.1093\/bioinformatics\/bty707 (2019).","journal-title":"Bioinformatics"},{"key":"34214_CR77","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2147\/OTT.S293685","volume":"14","author":"Y Lv","year":"2021","unstructured":"Lv, Y., Ma, X., Du, Y. & Feng, J. Understanding patterns of brain metastasis in triple-negative breast cancer and exploring potential therapeutic targets. Onco. Targets. Ther. 14, 589\u2013607. https:\/\/doi.org\/10.2147\/OTT.S293685 (2021).","journal-title":"Onco. Targets. Ther."},{"key":"34214_CR78","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","volume":"158","author":"A Kalliokoski","year":"2009","unstructured":"Kalliokoski, A. & Niemi, M. Impact of OATP transporters on pharmacokinetics. Br. J. Pharmacol. 158, 693\u2013705 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"34214_CR79","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.bcp.2019.07.026","volume":"168","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. & Hagenbuch, B. Protein\u2013protein interactions of drug uptake transporters that are important for liver and kidney. Biochem. Pharmacol. 168, 384\u2013391 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"34214_CR80","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00280-020-04181-2","volume":"87","author":"MC Stipp","year":"2021","unstructured":"Stipp, M. C. & Acco, A. Involvement of cytochrome P450 enzymes in inflammation and cancer: A review. Cancer Chemother. Pharmacol. 87, 295\u2013309 (2021).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"34214_CR81","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3\u201326 (2001).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"34214_CR82","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cmdc.200700139","volume":"3","author":"R Brenk","year":"2008","unstructured":"Brenk, R. et al. Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem 3, 435\u2013444 (2008).","journal-title":"ChemMedChem"},{"key":"34214_CR83","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1111\/cas.14648","volume":"111","author":"L Song","year":"2020","unstructured":"Song, L. et al. Icariin-induced inhibition of SIRT6\/NF-\u03baB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer. Cancer Sci. 111, 4242\u20134256 (2020).","journal-title":"Cancer Sci."},{"key":"34214_CR84","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.tibs.2021.01.014","volume":"46","author":"N Pandey","year":"2021","unstructured":"Pandey, N. & Black, B. E. Rapid detection and signaling of DNA damage by PARP-1. Trends Biochem. Sci. 46, 744\u2013757 (2021).","journal-title":"Trends Biochem. Sci."},{"key":"34214_CR85","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1101\/gad.183509.111","volume":"26","author":"X Luo","year":"2012","unstructured":"Luo, X. & Lee Kraus, W. On par with PARP: Cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev. 26, 417\u2013432 (2012).","journal-title":"Genes Dev."},{"key":"34214_CR86","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev-med-050913-022545","volume":"66","author":"CJ Lord","year":"2015","unstructured":"Lord, C. J., Tutt, A. N. J. & Ashworth, A. Synthetic lethality and cancer therapy: Lessons learned from the development of PARP inhibitors. Annu. Rev. Med. 66, 455\u2013470 (2015).","journal-title":"Annu. Rev. Med."},{"key":"34214_CR87","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1007\/s00432-022-04189-6","volume":"149","author":"A Mandapati","year":"2023","unstructured":"Mandapati, A. & Lukong, K. E. Triple negative breast cancer: Approved treatment options and their mechanisms of action. J. Cancer Res. Clin. Oncol. 149, 3701\u20133719 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"34214_CR88","doi-asserted-by":"publisher","first-page":"103125","DOI":"10.1016\/j.dnarep.2021.103125","volume":"103","author":"JO Spiegel","year":"2021","unstructured":"Spiegel, J. O., Van Houten, B. & Durrant, J. D. PARP1: Structural insights and pharmacological targets for inhibition. DNA Repair (Amst) 103, 103125 (2021).","journal-title":"DNA Repair (Amst)"},{"key":"34214_CR89","doi-asserted-by":"publisher","first-page":"9575","DOI":"10.1021\/acs.jmedchem.6b00055","volume":"59","author":"Y-Q Wang","year":"2016","unstructured":"Wang, Y.-Q. et al. An update on poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and challenges in cancer therapy. J. Med. Chem. 59, 9575\u20139598 (2016).","journal-title":"J. Med. Chem."},{"key":"34214_CR90","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1101\/gad.334516.119","volume":"34","author":"D Slade","year":"2020","unstructured":"Slade, D. PARP and PARG inhibitors in cancer treatment. Genes Dev. 34, 360\u2013394 (2020).","journal-title":"Genes Dev."},{"key":"34214_CR91","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1002\/cncr.26576","volume":"118","author":"A-R Hartman","year":"2012","unstructured":"Hartman, A.-R. et al. Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer. Cancer 118, 2787\u20132795 (2012).","journal-title":"Cancer"},{"key":"34214_CR92","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1158\/1078-0432.CCR-16-2401","volume":"23","author":"TM Cardillo","year":"2017","unstructured":"Cardillo, T. M. et al. Synthetic lethality exploitation by an anti-trop-2-SN-38 antibody-drug conjugate, IMMU-132, plus PARP inhibitors in BRCA1\/2-wild-type triple-negative breast cancer. Clin. Cancer Res. 23, 3405\u20133415 (2017).","journal-title":"Clin. Cancer Res."},{"key":"34214_CR93","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1158\/1078-0432.CCR-18-0204","volume":"24","author":"N Pulliam","year":"2018","unstructured":"Pulliam, N. et al. An effective epigenetic-PARP inhibitor combination therapy for breast and ovarian cancers independent of BRCA mutations. Clin. Cancer Res. 24, 3163\u20133175 (2018).","journal-title":"Clin. Cancer Res."},{"key":"34214_CR94","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1158\/0008-5472.CAN-17-1494","volume":"78","author":"JPW Carey","year":"2018","unstructured":"Carey, J. P. W. et al. Synthetic lethality of PARP inhibitors in combination with MYC blockade is independent of BRCA status in triple-negative breast cancer. Cancer Res. 78, 742\u2013757 (2018).","journal-title":"Cancer Res."},{"key":"34214_CR95","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.3390\/cancers15143642","volume":"15","author":"S Dilmac","year":"2023","unstructured":"Dilmac, S. & Ozpolat, B. Mechanisms of PARP-inhibitor-resistance in BRCA-mutated breast cancer and new therapeutic approaches. Cancers (Basel) 15, 3642 (2023).","journal-title":"Cancers (Basel)"},{"key":"34214_CR96","doi-asserted-by":"publisher","first-page":"11441","DOI":"10.3390\/ijms222111441","volume":"22","author":"NV Maluchenko","year":"2021","unstructured":"Maluchenko, N. V., Feofanov, A. V. & Studitsky, V. M. PARP-1-associated pathological processes: Inhibition by natural polyphenols. Int. J. Mol. Sci. 22, 11441 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"34214_CR97","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bbrc.2020.04.022","volume":"533","author":"J Li","year":"2020","unstructured":"Li, J. et al. A DNA-encoded library for the identification of natural product binders that modulate poly (ADP-ribose) polymerase 1, a validated anti-cancer target. Biochem. Biophys. Res. Commun. 533, 241\u2013248 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"34214_CR98","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bcp.2019.03.028","volume":"167","author":"D Slade","year":"2019","unstructured":"Slade, D. Mitotic functions of poly(ADP-ribose) polymerases. Biochem. Pharmacol. 167, 33\u201343 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"34214_CR99","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nature03061","volume":"432","author":"P Chang","year":"2004","unstructured":"Chang, P., Jacobson, M. K. & Mitchison, T. J. Poly(ADP-ribose) is required for spindle assembly and structure. Nature 432, 645\u2013649 (2004).","journal-title":"Nature"},{"key":"34214_CR100","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1038\/onc.2017.40","volume":"36","author":"V Colicchia","year":"2017","unstructured":"Colicchia, V. et al. PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma. Oncogene 36, 4682\u20134691 (2017).","journal-title":"Oncogene"},{"key":"34214_CR101","first-page":"6895","volume":"16","author":"MK Kim","year":"2018","unstructured":"Kim, M. K. Novel insight into the function of tankyrase. Oncol. Lett. 16, 6895\u20136902 (2018).","journal-title":"Oncol. Lett."},{"key":"34214_CR102","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ncb1322","volume":"7","author":"P Chang","year":"2005","unstructured":"Chang, P., Coughlin, M. & Mitchison, T. J. Tankyrase-1 polymerization of poly(ADP-ribose) is required for spindle structure and function. Nat. Cell Biol. 7, 1133\u20131139 (2005).","journal-title":"Nat. Cell Biol."},{"key":"34214_CR103","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.bbrc.2010.03.021","volume":"394","author":"Y Yashiroda","year":"2010","unstructured":"Yashiroda, Y. et al. A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor. Biochem. Biophys. Res. Commun. 394, 569\u2013573 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"34214_CR104","doi-asserted-by":"publisher","first-page":"5244","DOI":"10.1021\/acs.jmedchem.1c02139","volume":"65","author":"M Yu","year":"2022","unstructured":"Yu, M., Yang, Y., Sykes, M. & Wang, S. Small-molecule inhibitors of tankyrases as prospective therapeutics for cancer. J. Med. Chem. 65, 5244\u20135273 (2022).","journal-title":"J. Med. Chem."},{"key":"34214_CR105","doi-asserted-by":"publisher","first-page":"7880","DOI":"10.1021\/jm401463y","volume":"56","author":"M Narwal","year":"2013","unstructured":"Narwal, M. et al. Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity. J. Med. Chem. 56, 7880\u20137889 (2013).","journal-title":"J. Med. Chem."},{"key":"34214_CR106","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1021\/acs.jmedchem.6b00990","volume":"60","author":"A-G Thorsell","year":"2017","unstructured":"Thorsell, A.-G. et al. Structural basis for potency and promiscuity in poly(ADP-ribose) polymerase (PARP) and tankyrase inhibitors. J. Med. Chem. 60, 1262\u20131271 (2017).","journal-title":"J. Med. Chem."},{"key":"34214_CR107","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1016\/j.bmc.2018.06.019","volume":"26","author":"S Di Micco","year":"2018","unstructured":"Di Micco, S. et al. Identification by inverse virtual screening of magnolol-based scaffold as new tankyrase-2 inhibitors. Bioorg. Med. Chem. 26, 3953\u20133957 (2018).","journal-title":"Bioorg. Med. Chem."},{"key":"34214_CR108","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1021\/acsmedchemlett.9b00654","volume":"11","author":"S Tomassi","year":"2020","unstructured":"Tomassi, S. et al. From PARP1 to TNKS2 inhibition: A structure-based approach. ACS Med. Chem. Lett. 11, 862\u2013868. https:\/\/doi.org\/10.1021\/acsmedchemlett.9b00654 (2020).","journal-title":"ACS Med. Chem. Lett."},{"key":"34214_CR109","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/S0960-894X(97)00343-0","volume":"7","author":"M Marder","year":"1997","unstructured":"Marder, M. et al. Synthesis of halogenated\/nitrated flavone derivatives and evaluation of their affinity for the central benzodiazepine receptor. Bioorganic Med. Chem. Lett. 7, 2003\u20132008 (1997).","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"34214_CR110","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1006\/bbrc.1998.9146","volume":"249","author":"M Marder","year":"1998","unstructured":"Marder, M. et al. Detection of benzodiazepine receptor ligands in small libraries of flavone derivatives synthesized by solution phase combinatorial chemistry. Biochem. Biophys. Res. Commun. 249, 481\u2013485 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"34214_CR111","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41419-022-04520-6","volume":"13","author":"P Carabias","year":"2022","unstructured":"Carabias, P. et al. Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression. Cell Death Dis. 13, 79 (2022).","journal-title":"Cell Death Dis."},{"key":"34214_CR112","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41416-019-0636-x","volume":"122","author":"MB Nicoud","year":"2020","unstructured":"Nicoud, M. B. et al. Study of the antitumour effects and the modulation of immune response by histamine in breast cancer. Br. J. Cancer 122, 348\u2013360 (2020).","journal-title":"Br. J. Cancer"},{"key":"34214_CR113","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.bbamcr.2019.03.010","volume":"1866","author":"F Ferragut","year":"2019","unstructured":"Ferragut, F. et al. Dual knockdown of galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM\/CD166), synergistically delays in vivo breast cancer growth. Biochim. Biophys. Acta Mol. Cell Res. 1866, 1338\u20131352 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"34214_CR114","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","volume":"50","author":"DA Filimonov","year":"2014","unstructured":"Filimonov, D. A. et al. Prediction of the biological activity spectra of organic compounds using the pass online web resource. Chem. Heterocycl. Compd. 50, 444\u2013457 (2014).","journal-title":"Chem. Heterocycl. Compd."},{"key":"34214_CR115","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357\u2013W364 (2019).","journal-title":"Nucleic Acids Res."},{"key":"34214_CR116","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10822-016-9915-2","volume":"30","author":"Z-J Yao","year":"2016","unstructured":"Yao, Z.-J. et al. TargetNet: A web service for predicting potential drug-target interaction profiling via multi-target SAR models. J. Comput. Aided. Mol. Des. 30, 413\u2013424 (2016).","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"34214_CR117","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12859-017-1960-x","volume":"18","author":"K Lee","year":"2017","unstructured":"Lee, K., Lee, M. & Kim, D. Utilizing random Forest QSAR models with optimized parameters for target identification and its application to target-fishing server. BMC Bioinf. 18, 567. https:\/\/doi.org\/10.1186\/s12859-017-1960-x (2017).","journal-title":"BMC Bioinf."},{"key":"34214_CR118","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nbt1284","volume":"25","author":"MJ Keiser","year":"2007","unstructured":"Keiser, M. J. et al. Relating protein pharmacology by ligand chemistry. Nat. Biotechnol. 25, 197\u2013206 (2007).","journal-title":"Nat. Biotechnol."},{"key":"34214_CR119","doi-asserted-by":"publisher","first-page":"W26","DOI":"10.1093\/nar\/gku477","volume":"42","author":"J Nickel","year":"2014","unstructured":"Nickel, J. et al. SuperPred: Update on drug classification and target prediction. Nucleic Acids Res. 42, W26-31 (2014).","journal-title":"Nucleic Acids Res."},{"key":"34214_CR120","unstructured":"Molecular Operating Environment (MOE) 2024 Chemical Computing Group ULC. 910\u20131010 at https:\/\/www.chemcomp.com (2024)."},{"key":"34214_CR121","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ejmech.2017.11.071","volume":"143","author":"MD Santi","year":"2018","unstructured":"Santi, M. D. et al. Xanthine oxidase inhibitory activity of natural and hemisynthetic flavonoids from Gardenia oudiepe (Rubiaceae) in vitro and molecular docking studies. Eur. J. Med. Chem. 143, 577\u2013582 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"34214_CR122","doi-asserted-by":"crossref","unstructured":"Peralta, M. A., Santi, M. D., Cabrera, J. L. & Ortega, M. G. Dalea genus, chemistry, and bioactivity studies. In: Studies in Natural Products Chemistry (ed. Atta-ur-Rahman, B. T.-S. in N. P. C.) vol. 62 307\u2013341 (Elsevier, 2019).","DOI":"10.1016\/B978-0-444-64185-4.00008-3"},{"key":"34214_CR123","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ejps.2017.06.028","volume":"106","author":"D Carvalho","year":"2017","unstructured":"Carvalho, D. et al. Structural evidence of quercetin multi-target bioactivity: A reverse virtual screening strategy. Eur. J. Pharm. Sci. 106, 393\u2013403 (2017).","journal-title":"Eur. J. Pharm. Sci."},{"key":"34214_CR124","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang, E. et al. End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: Strategies and applications in drug design. Chem. Rev. 119, 9478\u20139508 (2019).","journal-title":"Chem. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34214-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34214-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34214-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:03:01Z","timestamp":1773795781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34214-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":124,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34214"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34214-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"4164"}}